NOV 01, 2018 2:12 PM PDT

Researchers Link Parkinson's Disease and the Appendix

WRITTEN BY: Carmen Leitch

Researchers have found that when a person’s appendix is removed early in life, it reduced their chances of getting Parkinson’s disease by 19 to 25 percent. The appendix holds alpha-synuclein proteins that are not folded correctly. Those proteins have been connected to the onset and progressions of Parkinson’s. The work, which was reported in Science Translational Medicine, also confirmed that the immune system and the gut play roles in the development of the disease.

Aggregated alpha-synuclein in the neurons of the appendix. / Credit: Courtesy of Viviane Labrie | Van Andel Research Institute

"Our results point to the appendix as a site of origin for Parkinson's and provide a path forward for devising new treatment strategies that leverage the gastrointestinal tract's role in the development of the disease," said the senior author of the report, Viviane Labrie, Ph.D., an assistant professor at Van Andel Research Institute (VARI). She is featured in the video below. "Despite having a reputation as largely unnecessary, the appendix actually plays a major part in our immune systems, in regulating the makeup of our gut bacteria and now, as shown by our work, in Parkinson's disease."

Generally, people that had an appendectomy were 19 percent less likely to get the disease, years before the onset of the disease. If it had been taken out after the illness began, there was no effect. Even in those who eventually got the disease, an appendectomy seemed to add about 3.6 years to the age of diagnosis.

The effect was more drastic in people that lived in rural areas - they were 25 percent less likely to develop the illness. Parkinson’s tends to be more prevalent in rural areas; it’s been thought that pesticide exposure is to blame.

Appendectomies had no impact on people with a family history of the disease, however. Genetic factors are responsible for around ten percent or less of Parkinson’s cases.

"Our findings today add a new layer to our understanding of this incredibly complex disease," noted first author Bryan Killinger, Ph.D., a postdoctoral fellow in the Labrie laboratory. "We have shown that the appendix is a hub for the accumulation of clumped forms of alpha-synuclein proteins, which are implicated in Parkinson's disease. This knowledge will be invaluable as we explore new prevention and treatment strategies."

The researchers identified clumps of alpha-synuclein proteins in the appendixes of both Parkison’s patients and healthy people. It had been assumed that alpha-synuclein clumps were a hallmark of Parkinson’s that would not be found in healthy people.

"We were surprised that pathogenic forms of alpha-synuclein were so pervasive in the appendixes of people both with and without Parkinson's. It appears that these aggregates, although toxic when in the brain, are quite normal when in the appendix. This clearly suggests their presence alone cannot be the cause of the disease," Labrie said. "Parkinson's is relatively rare - less than one percent of the population - so there has to be some other mechanism or confluence of events that allows the appendix to affect Parkinson's risk. That's what we plan to look at next; which factor or factors tip the scale in favor of Parkinson's?"

This study used data from two large health databases. One was the Swedish National Patient Registry, containing health information for the entire population of Sweden since 1964 - or 1,698,000 people followed for up to 52 years. The other was from Parkinson's Progression Marker Initiative (PPMI), which has a variety of Parkinson’s patient information.

 

Sources: AAAS/Eurekalert! via Van Andel Research Institute, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
APR 22, 2021
Genetics & Genomics
A Novel Mechanism of Gene Regulation is Revealed
APR 22, 2021
A Novel Mechanism of Gene Regulation is Revealed
For simplicity's sake, DNA is though of as a double-stranded molecule made of nucleotide bases A, G, C, and T, and RNA a ...
MAY 05, 2021
Microbiology
Is This the Missing Link?
MAY 05, 2021
Is This the Missing Link?
An image of Bicellum brasieri by Prof P.K. Strother. The fossil suggests multicellular structures existed 400 million ye ...
MAY 10, 2021
Cell & Molecular Biology
Getting RNA-Based Medicine Past the Blood-Brain Barrier
MAY 10, 2021
Getting RNA-Based Medicine Past the Blood-Brain Barrier
RNA molecules serve several functions, one of which is to help the cell generate proteins from active genes. It also may ...
MAY 17, 2021
Immunology
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
MAY 17, 2021
Understanding Inflammation: A Faster, Easier Way to Detect Cytokines in Cells
Inflammation, a process that was meant to defend our body from infection, has been found to contribute to a wide range o ...
JUN 07, 2021
Cardiology
Researchers Find a Way to Improve Outcomes After a Heart Attack
JUN 07, 2021
Researchers Find a Way to Improve Outcomes After a Heart Attack
It's thought that in the United States, there is a heart attack once every 40 seconds, or that each year, about 80,0 ...
Loading Comments...